{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:27:23Z","timestamp":1791822443898,"version":"4.3.4"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T00:00:00Z","timestamp":1521417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,2]]},"DOI":"10.1093\/infdis\/jiy137","type":"journal-article","created":{"date-parts":[[2018,3,17]],"date-time":"2018-03-17T04:32:18Z","timestamp":1521261138000},"page":"355-364","source":"Crossref","is-referenced-by-count":90,"title":["Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination"],"prefix":"10.1093","volume":"218","author":[{"given":"Amy K","family":"Winter","sequence":"first","affiliation":[{"name":"Department of Ecology and Evolutionary Biology, Princeton University, Princeton, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela E","family":"Martinez","sequence":"additional","affiliation":[{"name":"Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicity T","family":"Cutts","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J","family":"Moss","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt J","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease Dynamics, The Pennsylvania State University, State College, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalie","family":"McKee","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease Dynamics, The Pennsylvania State University, State College, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Lessler","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyla","family":"Hayford","sequence":"additional","affiliation":[{"name":"International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacco","family":"Wallinga","sequence":"additional","affiliation":[{"name":"Netherlands National Institute for Public Health and the Environment, Bilthoven, Netherlands"},{"name":"Leiden University Medical Center, Leiden, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Jess E","family":"Metcalf","sequence":"additional","affiliation":[{"name":"Department of Ecology and Evolutionary Biology, Princeton University, Princeton, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,19]]},"reference":[{"key":"key\n\t\t\t\t20180717031100_CIT0001","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/381592","article-title":"The theory of measles elimination: implications for the design of elimination strategies","volume":"189","author":"Gay","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180717031100_CIT0002","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/CDLI.11.1.119-122.2004","article-title":"Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 Sao Paulo epidemic","volume":"11","author":"Pannuti","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"key\n\t\t\t\t20180717031100_CIT0003","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1017\/S0950268801005234","article-title":"The seroepidemiology of measles in Western Europe","volume":"126","author":"de Melker","year":"2001","journal-title":"Epidemiol Infect"},{"key":"key\n\t\t\t\t20180717031100_CIT0004","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.15585\/mmwr.mm6642a6","article-title":"Progress toward regional measles elimination\u2014worldwide, 2000\u20132016","volume":"66","author":"Dabbagh","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180717031100_CIT0005","volume-title":"Global Measles and Rubella: Strategic Plan 2012\u20132020","author":"World Health Organization","year":"2012"},{"key":"key\n\t\t\t\t20180717031100_CIT0006","doi-asserted-by":"crossref","first-page":"D91","DOI":"10.1016\/j.vaccine.2011.04.059","article-title":"Measles and rubella eradication in the Americas","volume":"29","author":"Andrus","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180717031100_CIT0007","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1473-3099(17)30421-8","article-title":"Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis","volume":"17","author":"Trentini","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180717031100_CIT0008","first-page":"205","article-title":"Measles vaccines: WHO position paper","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180717031100_CIT0009","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1126\/science.aaa3438","article-title":"Reduced vaccination and the risk of measles and other childhood infections post-Ebola","volume":"347","author":"Takahashi","year":"2015","journal-title":"Science"},{"key":"key\n\t\t\t\t20180717031100_CIT0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1890\/0012-9615(2002)072[0169:DOMEES]2.0.CO;2","article-title":"Dynamics of measles epidemics: estimating scaling of transmission rates using a time series SIR model","volume":"72","author":"Bjornstad","year":"2002","journal-title":"Ecol Monogr"},{"key":"key\n\t\t\t\t20180717031100_CIT0011","doi-asserted-by":"crossref","first-page":"e1001404","DOI":"10.1371\/journal.pmed.1001404","article-title":"Measuring coverage in MNCH: design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveys","volume":"10","author":"Cutts","year":"2013","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180717031100_CIT0012","doi-asserted-by":"crossref","first-page":"e1001110","DOI":"10.1371\/journal.pmed.1001110","article-title":"Measuring the performance of vaccination programs using cross-sectional surveys: a likelihood framework and retrospective analysis","volume":"8","author":"Lessler","year":"2011","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180717031100_CIT0013","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180717031100_CIT0014","first-page":"86","article-title":"Rubella vaccines: WHO position paper","author":"World Health Organization","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180717031100_CIT0015","article-title":"The immunological basis for immunization series: module 7: measles\u2014Update 2009","volume-title":"Immunization Vaccines and Biologicals","author":"Moss","year":"2009"},{"key":"key\n\t\t\t\t20180717031100_CIT0016","article-title":"Immunological basis for immunization: module 11: rubella","volume-title":"Immunization Vaccines and Biologicals","author":"Best","year":"2008"},{"key":"key\n\t\t\t\t20180717031100_CIT0017","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/tmi.12737","article-title":"Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries","volume":"21","author":"Cutts","year":"2016","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20180717031100_CIT0018","doi-asserted-by":"crossref","first-page":"e67639","DOI":"10.1371\/journal.pone.0067639","article-title":"Balancing evidence and uncertainty when considering rubella vaccine introduction","volume":"8","author":"Lessler","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180717031100_CIT0019","first-page":"69","article-title":"Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella","volume":"75","author":"Robertson","year":"1997","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180717031100_CIT0020","doi-asserted-by":"crossref","first-page":"e1002255","DOI":"10.1371\/journal.pmed.1002255","article-title":"Demographic transition and the dynamics of measles in six provinces in China: a modeling study","volume":"14","author":"Li","year":"2017","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180717031100_CIT0021","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3201\/eid1902.120301","article-title":"Lessons and challenges for measles control from unexpected large outbreak, Malawi","volume":"19","author":"Minetti","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180717031100_CIT0022","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/rmv.1980050105","article-title":"The contribution of field tests to measles surveillance and control: a review of available methods","volume":"5","author":"Cutts","year":"1995","journal-title":"Rev Med Virol"},{"key":"key\n\t\t\t\t20180717031100_CIT0023","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jit143","article-title":"Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage","volume":"208","author":"Waaijenborg","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180717031100_CIT0024","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1016\/j.vaccine.2016.10.072","article-title":"Inferring rubella outbreak risk from seroprevalence data in Belgium","volume":"34","author":"Abrams","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180717031100_CIT0025","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1016\/j.vaccine.2016.06.006","article-title":"A review of testing used in seroprevalence studies on measles and rubella","volume":"34","author":"Dimech","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180717031100_CIT0026","volume-title":"Committee of NESVPD in National Institute of Infectious Diseases: Procedure for the National Epidemiological Surveillance of Vaccine-Preventable Diseases; 2005\u20132015","author":"Infectious Disease Surveillance Center, National Institute of Infectious Diseases, National Epidemiological Surveillance of Vaccine-Preventable Diseases (NESVPD). Ministry of Health Labour and Welfare(MHLW)"},{"key":"key\n\t\t\t\t20180717031100_CIT0027","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1071\/NB03027","article-title":"Australia\u2019s national serosurveillance program","volume":"14","author":"Gidding","year":"2003","journal-title":"N S W Public Health Bull"},{"key":"key\n\t\t\t\t20180717031100_CIT0028","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2807\/esm.02.04.00167-en","article-title":"The European Sero-Epidemiology Network (ESEN)","volume":"2","author":"Osborne","year":"1997","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20180717031100_CIT0029","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0950268800058209","article-title":"Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy","volume":"115","author":"Gay","year":"1995","journal-title":"Epidemiol Infect"},{"key":"key\n\t\t\t\t20180717031100_CIT0030","first-page":"R17","article-title":"The epidemiology of measles in England and Wales since the 1994 vaccination campaign","volume":"7","author":"Gay","year":"1997","journal-title":"Commun Dis Rep CDR Rev"},{"key":"key\n\t\t\t\t20180717031100_CIT0031","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1093\/infdis\/jir129","article-title":"Changing epidemiology of measles in Africa","volume":"204","author":"Goodson","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180717031100_CIT0032","doi-asserted-by":"crossref","first-page":"e1002144","DOI":"10.1371\/journal.pmed.1002144","article-title":"Impact on epidemic measles of vaccination campaigns triggered by disease outbreaks or serosurveys: a modeling study","volume":"13","author":"Lessler","year":"2016","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180717031100_CIT0033","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S0950268810001329","article-title":"Modelling the first dose of measles vaccination: the role of maternal immunity, demographic factors, and delivery systems","volume":"139","author":"Metcalf","year":"2011","journal-title":"Epidemiol Infect"},{"key":"key\n\t\t\t\t20180717031100_CIT0034","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12080-014-0250-8","article-title":"The effects of maternal immunity and age structure on population immunity to measles","volume":"8","author":"McKee","year":"2015","journal-title":"Theor Ecol"},{"key":"key\n\t\t\t\t20180717031100_CIT0035","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/522989","article-title":"The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants","volume":"45","author":"Scott","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180717031100_CIT0036","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1017\/S0950268801005830","article-title":"Impact of the Australian Measles Control Campaign on immunity to measles and rubella","volume":"127","author":"Gilbert","year":"2001","journal-title":"Epidemiol Infect"},{"key":"key\n\t\t\t\t20180717031100_CIT0037","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/j.vaccine.2008.07.005","article-title":"Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys","volume":"26","author":"Nigatu","year":"2008","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180717031100_CIT0038","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1017\/S0950268808000848","article-title":"Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models","volume":"137","author":"Ohuma","year":"2009","journal-title":"Epidemiol Infect"},{"key":"key\n\t\t\t\t20180717031100_CIT0039","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2105\/AJPH.90.10.1555","article-title":"Unseen blindness, unheard deafness, and unrecorded death and disability: congenital rubella in Kumasi, Ghana","volume":"90","author":"Lawn","year":"2000","journal-title":"Am J Public Health"},{"key":"key\n\t\t\t\t20180717031100_CIT0040","doi-asserted-by":"crossref","first-page":"e0149160","DOI":"10.1371\/journal.pone.0149160","article-title":"Using seroprevalence and immunisation coverage data to estimate the global burden of congenital rubella syndrome, 1996\u20132010: a systematic review","volume":"11","author":"Vynnycky","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180717031100_CIT0041","first-page":"89","article-title":"Framework for verifying elimination of measles and rubella","volume":"88","author":"World Health Organization","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180717031100_CIT0042","volume-title":"Guidelines of Verification of Measles Elimiation in the Western Pacific Region","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180717031100_CIT0043","doi-asserted-by":"crossref","first-page":"15585","DOI":"10.1038\/ncomms15585","article-title":"The geography of measles vaccination in the African Great Lakes region","volume":"8","author":"Takahashi","year":"2017","journal-title":"Nat Commun"},{"key":"key\n\t\t\t\t20180717031100_CIT0044","volume-title":"Surveillance Guidelines for Measles, Rubella and Congenital Rubella Syndrome in the WHO European Region","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180717031100_CIT0045","volume-title":"Performance of Enzyme Immunoassays for HIV Serology in Surveys Donducted by the Demographic and Health Surveys Program. DHS Comparative Reports No 39","author":"Fishel","year":"2016"},{"key":"key\n\t\t\t\t20180717031100_CIT0046","volume-title":"Vaccination Coverage Cluster Survey: Reference Manual, Version 3 Working Draft (updated July 2015): Immunization Vaccines and Biologicals","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180717031100_CIT0047","doi-asserted-by":"crossref","first-page":"438","DOI":"10.15585\/mmwr.mm6517a3","article-title":"Global measles and rubella laboratory network support for elimination goals, 2010\u20132015","volume":"65","author":"Mulders","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180717031100_CIT0048","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcv.2015.11.022","article-title":"Performance of 14 rubella IgG immunoassays on samples with low positive or negative haemagglutination inhibition results","volume":"74","author":"Huzly","year":"2016","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t20180717031100_CIT0049","article-title":"Statistics for biology and health","volume-title":"Modeling Infectious Disease Parameters Based on Serological and Social Contact Data: A Modern Statistical Perspective","author":"Hens","year":"2012"},{"key":"key\n\t\t\t\t20180717031100_CIT0050","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles antibody: reevaluation of protective titers","volume":"162","author":"Chen","year":"1990","journal-title":"J Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/3\/355\/25168696\/jiy137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T11:52:41Z","timestamp":1603972361000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/218\/3\/355\/4942536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,19]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,19]]},"published-print":{"date-parts":[[2018,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy137","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8,1]]},"published":{"date-parts":[[2018,3,19]]}}}